期刊文献+

Fas和Fas配体基因启动子单核苷酸多态性与子宫颈癌的发病风险 被引量:11

Association between Fas/Fas L genes promoter polymorphisms and pathogenic risk of cervical cancer
原文传递
导出
摘要 目的探讨凋亡相关基因Fas和Fas配体(Fas L)启动子区单核苷酸多态与宫颈癌发病风险的关系。方法采用PCR-限制性片段长度多态性方法,检测314例宫颈癌患者和615例正常对照者的外周静脉血Fas-670A/G、Fas-1377G/A和Fas L-844T/C多态位点的基因型。应用多因素Logistic回归分析基因多态与宫颈癌风险的相关性以及与宫颈癌临床病理特征的关系。结果携带Fas L-844CC基因型者患宫颈癌风险较携带Fas L-844TT基因型者增加3.05倍(P〈0.01);Fas-670A/G和Fas-1377G/A均与宫颈癌发病风险无关;Fas和Fas L基因多态间存在协同作用。分层研究显示,Fas-670G和Fas-1377A等位基因是患宫颈原位鳞癌的危险因素(OR分别为1.77和1.93;P〈0.05)。Fas L-844CC基因型携带者患宫颈浸润性鳞癌的风险较Fas L-844TT基因型携带者增加(OR=3.33;P〈0.01)。Fas和Fas L基因多态与宫颈癌临床分期、细胞分级、肿瘤大小和血清鳞状上皮细胞癌抗原等无关。结论Fas和Fas L基因多态与子宫颈癌遗传易感性相关。 Objective To investigate the association between apoptosis genes Fas/Fas L promoter polymorphisms and the risk of the development of cervical cancer. Methods Blood samples were collected from 314 cases with primary cervical cancer and 615 healthy controls. Genotypes of Fas/Fas L genes were determined by polymerase chain reaction-based restriction fragment length polymorphism. The associations with the risk of cervical cancer and impact of clinicopathological characteristics were estimated by logistic regression. Results Fas L-844CC genotype was significantly associated with increased risk of cervical cancer compared with Fas L-844TC or -TT genotype ( OR = 3.05 ; P 〈 0.01 ). However, there was no significant difference of Fas-670A/G or -1377G/A genotypes. Interaction of genetic polymorphism between Fas and Fas L was observed. Stratification analysis revealed that Fas-670G or -1377A allele was significantly higher in squamous carcinoma in situ ( OR = 1.77 or 1.93 ; P 〈0.05) while Fas L-844CC genotype had an increased risk of invasive squamous carcinoma compared with that of Fas L-844TT genotype ( OR = 3.33 ; P 〈0.01). No significant associations were observed between polymorphisms in Fas/Fas L and clinical FIGO stage, cell differentiation, size of tumors, serum squamous cell carcinoma antigen value at the diagnosis and so on. Conclusion The results of this study suggest that genetic polymorphisms of Fas and Fas L in apoptotic pathway are associated with the risk of development of cervical carcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第1期38-41,共4页 Chinese Journal of Oncology
关键词 宫颈肿瘤 基因多态 FAS FAS L Cervix neoplasms Genetic polymorphism Fas Fas L
  • 相关文献

参考文献18

  • 1Humlg QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol, 1997, 34:577-582.
  • 2Sibley K, Rollinson S, Allan JM, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res, 2003, 63:4327-4330.
  • 3Wu J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancerbinding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. Immunol, 2003, 170 : 132-138.
  • 4Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol, 2004, 103:304- 309.
  • 5Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst, 2004, 96:1030-1036.
  • 6Ju ST, Panka DJ, Cui H, et al. Fas( CD95 )/Fas L interactions required for programmed cell death after T-cell activation. Nature, 1995, 373:444-448.
  • 7Krammer PH. CD95's deadly mission in the immune system. Nature, 2000, 407:789-795.
  • 8Kim R, Emi M, Tanabe K, et al. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer, 2004, 100: 2281- 2291.
  • 9Reesink-Peters N, Hougardy BM, van den Heuvel FA, et al. Death receptors and ligands in cervical carcinogenesis: an immuno- histochemical study. Gynecol Oncol, 2005, 96:705-713.
  • 10Bekkers RL, Massuger LF, Bulten J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol, 2004, 14:95-105.

二级参考文献29

  • 1Salisbury. BA, Pungliya M, Choi JY, et al. SNP and haplotype variation in the hmnan genome. Mutat Res, 2003, 526: 53-61.
  • 2Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 1990, 250: 1684-1689.
  • 3Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature, 2001, 411: 199-204.
  • 4Wall JD, Pritchard JK. naplotype blocks and linkage disequilibrium inthe human genome. Nat Rev Genet, 2003, 4: 587-597.
  • 5Johnson GC, Espesito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet, 2001, 29: 233-237.
  • 6Longmate JA. Complexity and power in case-control association studies.Am J Hum Genet, 2001, 68: 1229-1237.
  • 7Carlson CS, Eberle MA, Rieder MJ, et al. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet, 2003, 33: 518-521.
  • 8Wu X, Zhao H, Amos CI, et al. p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Nail Cancer lnst, 2002, 94: 681-690.
  • 9Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 2003, 411:603 -606.
  • 10Patil N, Bemo A J, Hinds DA, et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of hmnan chromosome 21.Science, 2001, 294: 1719-1723.

共引文献44

同被引文献49

  • 1陈雅卿,吕卫国,田其方,叶枫,谢幸.Fas-670位点单核苷酸多态性与宫颈癌易感性关系的研究[J].中华医学杂志,2006,86(39):2792-2794. 被引量:6
  • 2黄金双,林蓓,齐跃,周丹,张淑兰.人类白细胞抗原DRB1等位基因多态性与子宫颈癌易感性的相关性研究[J].中华妇产科杂志,2006,41(10):715-716. 被引量:6
  • 3Ferlay JFB, Pisaniand P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2004.
  • 4Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocr Metab, 1997, 82:4130- 4132.
  • 5Chert L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4:336-347.
  • 6Bekkers RL, Massuger LF, Buhen J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol, 2004, 14:95-105.
  • 7Guzman VB, Yambaltsev A, Goncalves-Primo A, et al. New approach reveals C1)28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet, 2008, 17:1838-1844.
  • 8Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxie T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res, 2008, 68:7025-7034.
  • 9Cozar JM, Romero JM, Aptsiauri N, et al. High incidence of CTLA-4 AA ( CT60 ) polymorphism in renal cell cancer. Hum Immunol, 2007, 68:698-704.
  • 10Ghaderi A, Yeganeh F, Kalantari T, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat, 2004, 86:1-7.

引证文献11

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部